<DOC>
	<DOC>NCT00585260</DOC>
	<brief_summary>The overall hypotheses are: 1) an indirect airway challenge procedure using mannitol can safely characterize asthma phenotypes, predict asthma control and exacerbations, predict responses to interventions, and perform more specifically than a direct methacholine challenge and; 2) PX27 pore function in whole blood correlates with measures of airway hyperresponsiveness induced by methacholine and/or mannitol challenges</brief_summary>
	<brief_title>Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<mesh_term>Methacholine Chloride</mesh_term>
	<criteria>all subjects randomized to the BASALT protocol positive urine pregnancy test requirement for more than two albuterol treatments for reversal of the methacholine bronchoprovocation challenge procedure at visit 4 in the BASALT parent trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>asthma</keyword>
	<keyword>bronchoprovocation challenge test</keyword>
	<keyword>mannitol</keyword>
	<keyword>methacholine</keyword>
</DOC>